Featured Research

from universities, journals, and other organizations

Soft Contact Lens Corneal Infections Fueled By Resistant Microbes

Date:
January 29, 2008
Source:
University Hospitals of Cleveland
Summary:
Researchers find lens care solutions are inadequately tested with an outdated and irrelevant fungus strain. New research shows that corneal infections associated with soft contact lenses are fueled and made resistant to treatment by the formation of a highly resistant structure of microbial cells held together with a glue-like matrix material. Scientists call this conglomeration of cells biofilms.

In 2006, Bausch & Lomb withdrew its ReNu with MoistureLoc contact lens solution because a high proportion of corneal infections were associated with it. Now in a new study from University Hospitals Case Medical Center, researchers show that these infections were fueled and made resistant to treatment by the formation of a highly resistant structure of microbial cells held together with a glue-like matrix material. Scientists call this conglomeration of cells biofilms.

"Once they live in that type of state, the cells become resistant to lens solutions and immune to the body's own defense system," said Mahmoud A. Ghannoum, Ph.D., director of the Center for Medical Mycology at University Hospitals Case Medical Center and senior investigator of the study which appears in the January 2008 issue of the journal Antimicrobial Agents and Chemotherapy. "This study should alert contact lens wearers to the importance of proper care for contact lenses to protect against potentially virulent eye infections," he said.

"Biofilms are a constellation of resistant organisms," Dr. Ghannoum said. They were suspected with the spate of infections in 2005-2006, but until this study, there were no data to prove this. This is the first in-vitro model for cornea keratitis infections caused by the fungus Fusarium, which was one of the main culprits in the ReNu with Moisture Loc cases, and another fungus called Candida albicans.

The researchers also discovered that the strain of fungus (ATCC 36031) used for testing the effectiveness of lens care solutions is a strain that does not produce biofilms as the clinical fungal strains do. Lens care solutions currently are tested against an old and rare genotype fungal strain obtained in the 1970s from a patient from Nigeria. The contact lens solutions, therefore, are effective in the laboratory, but fail when faced with strains in real-world situations. "The multipurpose contact lens solutions cannot kill these germs, to put it simply," said Dr. Ghannoum.

"We recommend that solutions be tested for biofilms produced by more recent clinical isolates," said Dr. Ghannoum. "One of the underlying reasons for ReNu with MoistureLoc not being effective against the outbreak of keratitis is that the solution is not effective against biofilms and the organisms contained in biofilms."

The researchers tested six kinds of contact lenses made by three different manufacturers and two lens care solutions (Bausch & Lomb's MoistureLoc and MultiPlus) against three fungal strains (two recent clinical strains and the one from the 1970s) of Fusarium and one strain of C. albicans.

Since biofilm contamination of contact lens cases is a common finding, and ReNu with MoistureLoc is ineffective against fungal biofilm, the industry must ensure that their multipurpose solutions are effective against biofilms, said Dr. Ghannoum. In the meantime, extreme caution must be taken to ensure the contact lens care case is not contaminated with biofilm.

Dr. Ghannoum recommends that soft contact lens wearers use only fresh lens care solution, not add fresh solution to old solution, a phenomenon known as topping off, and use solution by expiration dates written on the package. He also recommends a rub and rinse method, regardless of which cleaning or disinfecting solution used (which also is recommended by the Centers for Disease Control and Prevention). An additional preventative measure to prohibit the development of biofilms is to ensure that the bottle caps and tips of multipurpose solutions are clean.

The study involved researchers in the Center for Medical Mycology, Department of Dermatology, and Department of Ophthalmology and Visual Sciences at University Hospitals Case Medical Center and Case Western Reserve University in Cleveland. The strains of fungus tested in the study were obtained from patients with fungal keratitis at University Hospitals Case Medical Center, the Cleveland Clinic Foundation, and the American Type Culture Collection (Manassas, Va.). This work was supported by funding from the National Institutes of Health.


Story Source:

The above story is based on materials provided by University Hospitals of Cleveland. Note: Materials may be edited for content and length.


Cite This Page:

University Hospitals of Cleveland. "Soft Contact Lens Corneal Infections Fueled By Resistant Microbes." ScienceDaily. ScienceDaily, 29 January 2008. <www.sciencedaily.com/releases/2008/01/080128113204.htm>.
University Hospitals of Cleveland. (2008, January 29). Soft Contact Lens Corneal Infections Fueled By Resistant Microbes. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/01/080128113204.htm
University Hospitals of Cleveland. "Soft Contact Lens Corneal Infections Fueled By Resistant Microbes." ScienceDaily. www.sciencedaily.com/releases/2008/01/080128113204.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins